POM-V Prescription Required Companion Animal

Inflacam 5 mg/ml Solution for Injection for Dogs and Cats

Active ingredient: Meloxicam

Form

Injection

Species

Cats Dogs

Manufacturer

Chanelle Pharmaceuticals Manufacturing Ltd

VMD MA No.

08749/5015

What it's used for

and soft tissue surgery. Cats Reduction of post-operative pain after ovariohysterectomy and minor soft tissue surgery.

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Meloxicam

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Inflacam 5 mg/ml Solution for Injection for Dogs and Cats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

and soft tissue surgery.
Cats
Reduction of post-operative pain after ovariohysterectomy and minor soft tissue
surgery.

Subcutaneous use (cats).
Dogs
Musculo-skeletal disorders:
Single subcutaneous injection at a dosage of 0.2 mg meloxicam/kg body weight (i.e.
0.4 ml/10 kg body weight).
Inflacam 1.5 mg/ml oral suspension for dogs or Inflacam 1 mg and 2.5 mg chewable
tablets for dogs may be used for continuation of treatment at a dosage of 0.1 mg
meloxicam/kg body weight, 24 hours after administration of the injection.
Reduction of post-operative pain (over a period of 24 hours):
Single intravenous or subcutaneous injection at a dosage of 0.2 mg meloxicam/kg
body weight (i.e. 0.4 ml/10 kg body weight) before surgery, for example at the time of
induction of anaesthesia.
Cats
Reduction of post-operative pain:
Single subcutaneous injection at a dosage of 0.3 mg meloxicam/kg body weight (i.e.
0.06 ml/kg body weight) before surgery, for example at the time of induction of
anaesthesia.
To ensure a correct dosage, body weight should be determined as accurately as
possible.
The use of suitably calibrated measuring equipment is recommended.
Avoid introduction of contamination during use.
Maximum number of piercings is 42 for all presentations.

Do not use in animals suffering from gastrointestinal disorders such as irritation and
haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders.
Do not use in case of hypersensitivity to the active substance or to any of the
excipients.
Do not use in animals less than 6 weeks of age nor in cats of less than 2 kg.
Refer to section 3.7.

Dogs and cats:
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Appetite loss, Lethargy
Vomiting, Diarrhoea, Blood in faeces
,
Haemorrhagic diarrhoea
, Haematemesis
,
Gastric ulcer
, Small intestine ulcer
, Large
intestine ulcer
Elevated liver enzymes
Renal failure
Anaphylactoid reaction
1
Occult
These side effects occur generally within the first treatment week and are in most
cases transient and disappear following termination of the treatment but in very rare
cases may be serious or fatal.
If such reaction occurs, it should be treated symptomatically.

If adverse reactions occur, treatment should be discontinued and the advice of a
veterinarian should be sought.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See also the package leaflet for
respective contact details.

None.

Special precautions for safe use in the target species:
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a
potential risk of renal toxicity.
During anaesthesia, monitoring and fluid therapy should be considered as standard
practice.
Any oral follow-up therapy using meloxicam or other NSAIDs should not be
administered in cats, as appropriate dosage regimens for such follow-up treatments
have not been established.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Accidental self-injection may give rise to pain.
People with known hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs)
should avoid contact with the veterinary medicinal product.
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.

Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances
with high protein binding may compete for binding and thus lead to toxic effects. The
veterinary medicinal product must not be administered in conjunction with other
NSAIDs or glucocorticosteroids. Concurrent administration of potential nephrotoxic
drugs should be avoided. In animals at anaesthetic risk (e.g. aged animals)
intravenous or subcutaneous fluid therapy during anaesthesia should be taken into
consideration. When anaesthesia and NSAID are concomitantly administered, a risk
for renal function cannot be excluded.
Pre-treatment with anti-inflammatory substances may result in additional or increased
adverse effects and accordingly a treatment-free period with such veterinary medicinal
products should be observed for at least 24 hours before commencement of treatment.
The treatment-free period should however take into account the pharmacological
properties of the veterinary medicinal products previously used.

Keep the vial in the outer carton.

Not applicable.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.